Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PAPL had a volatile session, and it soared as much as 28% to $1.15 in afternoon trading. However, the stock closed at $0.95 (pulled back on a low volume). The stock is still above the 20-day MA and looks good for $1.5.
$PAPL—Canada’s rate cut by 25 basis points is estimated to give a huge boost to the $2.1 trillion Canadian mortgage market. This could create a massive opportunity for Pineapple Financial Inc. (NYSE American: PAPL).
Following the rate cut, the company sees accelerated growth in user base and revenue.
https://finance.yahoo.com/news/2-1-trillion-canadian-mortgage-104500715.html
FWFW(.45)...disposal/acquisition transactions a couple of weeks ago.......
29.6M outstanding
452K unrestricted
400K DTC
I increased my position in FWFW yesterday by buying a little more than 15K shares at sub-45 cent prices. Ideally I would have liked to just bid sit, but my experience over the last couple of years on FWFW (difficult to buy, my high bids getting passed over, etc) made me want to be more aggressive with my buying.
FWFW disposed of its primary asset/business (QBS System) a couple of weeks ago and acquired a 9.38% equity position in Flywheel Financial Strategy (FFS). This is the company that was supposed to be the reverse merger target when Roy Tang first gained control of the shell. And that is what I thought I was buying into when I first started purchasing shares back in 2022. But they never actually vended FFS into the shell, and instead they acquired QBS System and also started forming a robot distribution company. To complicate matters, throughout all of this time the management/company has made it sound like the reverse merger between FWFW and FFS did in fact take place. So this has made for a somewhat confusing/puzzling situation over the years.
I don't know if they are now planning to acquire control of FFS or if these transactions are just part of some broader corporate strategy. The timing for entry/accumulation just seems particularly attractive to me at this moment in time. Investors seem to be a little more receptive recently to some of these low float plays. Given the current relatively tight share structure, and the fact that there appears to be some increase in corporate activity taking place, I would like to have a position built before any more potential catalysts might appear. It would be nice if FWFW turned into one of those sub-50 cent to multi-dollar type of plays.
$PAPL stock sees unusual volume action and after a 30% jump on Wednesday, the stock looks extremely bullish. Moreover, “EF Hutton” has a buy rating and price target of $5.50, potential jump of 590% from the CMP of $0.80.
As per the firm “Breakeven EBITDA Likely In December. An inflection point of breakeven adjusted EBITDA could be achieved this December. PAPL’s cost structure should benefit from a large reduction in its http://Salesforce.com enterprise expenses ($90,000 quarterly) as it does internal modules replacement (although not fully eliminate http://Salesforce.com), which we estimate could be $200,000 annual savings between December 2023 and December 2024. Keep $PAPL on your top radar as a low float could trigger a massive buy.”
R.I.P Bob Newhart and Lou Dobbs 😇😇
Thanks for all the memories...
Involuntary-Recluse...hopefully the SYBE tier change is just temporary.......
Expert market
The damage to the overall OTC market may very well be permanent at this point, but hopefully there will still be brief moments and stock-specific opportunities that make it worth monitoring at least a little bit. I still think ECGR could be one of those reasonably nice opportunities. The SEC's ban on auditor BF Borgers on May 3 certainly throws in a complicating factor for Borgers' OTC clients like ECGR. I don't know what kind of damage/fallout over the next few weeks/months this will cause for the OTC and Nasdaq stocks that were using that auditor, but I will probably consider adding to my position at sub-10 cent prices if there is significant weakness in ECGR.
As expected, $PAPL is flying today. Considering impressive quarterly earnings with revenue growth of over 20.43%, the stock is still undervalued and has potential to go up further. Now, $PAPL is trading above the 20-day MA and on the verge of breaking above the 50-day MA of 1.04. Once the stock breaches it, it may fill the gap to $1.50.
This week, Pineapple Financial (NYSE American: PAPL) reported that revenue soared 20.50% to $736,448.
Residential Mortgage Loans grew 22.72% to $377.64 million.
The company’s cash position is healthy with over $1 million as of May 31, 2024.
HOOD
I-R wants $32.50++++++++++
Thanks a lot DJT, always leaving the station without me 😂
SYBE(.0595)...accumulated a position.....
99.4M outstanding
3.03M unrestricted
1.25M DTC
SYBE had a change-in-control back around mid-April. I have accumulated a position in SYBE over the last couple of weeks or so. Currently averaged at a little under 4.2 cents per share (bought in the range of .0259 to .0599). The initial pop in share price following the control disclosure seemed to be smaller than I would have expected to see. I'm not sure if that was merely a result of poor market conditions or a reflection on the quality of the incoming company/management. Or a combination of the above.
There are the usual risks associated with a shell/RM here (details on the final structure and the incoming company are not clear yet, possible financing needs, etc, etc). It is always possible that the new control entity is just an intermediary rather than the RM target, which can complicate things when you do an analysis of the play. Plus we have the added thrill of a filing delinquency. A lot of things could dramatically change and go wrong here, but the risk/reward looks reasonably attractive to me right now. If I am looking at things correctly, Worldwide Holdings Investment Group now controls more than 95.5% of the SYBE shell. That leaves a legacy share count of a little over 4.4M shares. At the current price of 6 cents that is a legacy valuation of well under $300K. That kind of legacy valuation combined with the current share structure makes SYBE pretty hard to ignore.
I think this has the potential for some significant upside if the new management handles this merger in a shareholder-friendly manner. That is probably asking/wishing for too much, but you just never know which company/investment might pleasantly surprise you. The setup here is certainly intriguing. I will be disappointed if I walk away from SYBE with anything less than an average of 30 cents per share on my position.
Worldwide Holdings websites.......
https://wwhcorp.com/
https://wwhgroup.net/
SYBE CEO Jeremy Davey.......
https://www.linkedin.com/in/jeremy-davey-420120/
Stop teasing DJT, <$20.00 so i can load please
$TNXP gains momentum after presenting vaccine platform data at the Vaccine Congress 2024. The stock is due for a massive short squeeze and it could be right time. The stock may fill the gap to $1.65-1.75.
Here are key highlights from today’s news:-
TNX-801 vaccination demonstrated efficacy in protecting animals from lethal challenge with intratracheal monkeypox
Clade II mpox is now endemic in the U.S. with >30,000 cases reported since May 20221 and Clade I mpox is endemic in the Democratic Republic of the Congo2
Tonix’s vaccine platform has been selected by NIH’s Project NextGen for clinical testing
Vaccine Congress 2024. The stock is due for a massive short squeeze and it could be right time. The stock may fill the gap to $1.65-1.75.
Here are key highlights from today’s news:-
TNX-801 vaccination demonstrated efficacy in protecting animals from lethal challenge with intratracheal monkeypox
Clade II mpox is now endemic in the U.S. with >30,000 cases reported since May 20221 and Clade I mpox is endemic in the Democratic Republic of the Congo2
Tonix’s vaccine platform has been selected by NIH’s Project NextGen for clinical testing
$MMA Alta Global Group (NYSE American:MMA) announced its strategic acquisition of Hype for. Hype is a subscription-based mobile marketing platform designed to help small businesses grow in today's age of social media.
Hype's software platform strengthens Alta's vision to convert 640 million MMA fans to participants by providing invaluable tools.
Hype has processed over $40 million in payments through its platform, collected over 4 million contacts for current and previous customers, and generates revenue from recurring subscriptions and payment processing fees.
$TNXP soared another 11% on Thursday on hefty volume and closed at a HOD. The company made impressive progress on TonmyaTM and announced a positive pre-NDA CMC meeting with the FDA. Excitement is building as the company anticipates the official minutes, which might indicate substantial progress towards bringing the drug to market.
No doubt, this is big news and could trigger a short squeeze.
Also, in the second half, it is planning submit the NDA for Tonmya to the FDA.
$MMA stock has formed a nice based around $3 and once the volume picks up, it could see a nice rally towards $4.50. Just need some patience. Last week, Alta Global Group (NYSE American:MMA) had big news and partnered with Australian former UFC fighter Jessica-Rose Clark. By partnering with an esteemed and popular figure like Jessica-Rose Clark, Alta aims to strengthen its connection with the global MMA community, encouraging fans to actively participate in martial arts.
Excellent post, my good man.
YBGJ(1.04)...holding some shares for possible move higher.......
YBGJ had a high-volume pullback in late April, and has now moved back up nicely to an area of some resistance on the chart. I've been holding a position in YBGJ for a couple/few years. Sold a little under half my position (mostly in the .85 to $1.02 range) on this most recent move. Still holding some shares with a 10-cent cost basis and am looking to see if there will be more of a stronger move above this $1 area.
This movement in YBGJ is somewhat interesting in light of the massive move that LDSN experienced recently (sub 3 cents to over 90 cents). Maybe LDSN will ultimately turn out to be just a stock-specific situation but I am hoping that the LDSN performance might be a harbinger of increased interest in some of the Asia-related OTC stocks. We have seen the kind of wild/crazy moves many of the Asian stocks tend to have on Nasdaq. It would be nice to see some of that happen again down here in the stock sewer.
Gensler killed it...
imho
What happened to the OTC?
No way back for the OTC, my good man. imho
At least we have the memories
Good thing ASKH is working on that infamous S1 to up list LMAO 😂
"The Achilles Heel of ASKH has always been Mark Wayne Richards." Greater words have never been spoken
Hope all is well with you, my good man
INNI/MAYX...added to INNI position, still holding full MAYX position......
Accumulated some more shares of the INNI shell today to add to a starter position I had bought awhile ago. Although INNI still has the disadvantage of the name/symbol and 15-12G filing issues that I mentioned in the post above, I am thinking maybe the timing for entry/accumulation on INNI is looking a little more interesting right now. I'm not real confident about it, so I've kept my purchases mostly around this 1.5 cent area on the INNI shell. The legacy share valuation at that price area seems reasonably attractive to me and should provide some decent upside if David Duarte (Tailored Tickers) can find a RM candidate for the shell.
The reasons I have decided to add to my position now......
1) The other most comparable/similar Duarte shell (AFFL) has been trading recently at a valuation that is basically 2X what INNI trades at. So between those two shells INNI is significantly undervalued right now.
2) I do find it somewhat interesting that recently David chose to have INNI's financials audited. Maybe I shouldn't read too much into that, but that seems to be very different from how he has handled his other shells.
3) On one of his other shells (MAYX) around 920K shares were added to the outstanding share count this week, which increased the total outstanding to 1.3M shares. I don't know whether those shares are part of a RM transaction, or if they might be for things like services rendered. The statements in the MAYX periodic filings seemed to make it fairly clear to me that the MAYX shell was probably going to complete a RM sometime this year (see below), so with this share increase this week I think it is somewhat logical to assume/guess that there may be a change-in-control with the MAYX shell right now. As far as I am aware, there has not been any announcement/disclosure yet regarding the details on that share increase, but if the MAYX shell has indeed been sold my thinking is that this could bring some additional investor attention to his other shells. From the MAYX filings......
The issuer anticipates effectuating a forward split and/or acquiring an operating company via reverse merger in the
upcoming months.
GGEI will not stay at .02 mush longer…good chance to hit .03+ as soon as tomorrow…
GGEI this one can make one of the most historic runs the OTC has ever seen. The chart is incredibly bullish grinding higher after a desperation short ladder attack a week ago.
$GGEI if $136M gets brought back to assets due to impairment reversal, AND if company cancels half the OS like I mention here…that would bring shareholder equity to around $155M with an OS of 77.5M.
— J0L (@JolTrades) June 2, 2024
That would yield a share price of $2. So that target is definitely in play.… https://t.co/xCPJiC8VNa
"Because success and happiness live or die between your ears."
The real secret part deux lol..
"Once more, the way you talk to yourself, the inner dialogue that's running 24/7 in your mind, has a far greater impact on your success than any external factor."
The real secret!!!!
If i am correct in thinking that the next BTC breakout touches $100k, then i must raise my HOOD target to $35-40ish.
Adjusted GTC sell @ $27.50 to $35.00
imho
HOOD $23.69 Chugging along 😂
$ABL - $ABLW
Abacus Life (NASDAQ: ABL) announced that it led the life settlement industry in 2023 with a 26% market share in funds paid to clients, according to The Deal's annual ranking.
The company paid $220 million in life settlement funds, equivalent to over 20% of policy face value on average, which is 32% higher than its closest competitor.
Additionally, Abacus acquired 640 policies with a collective face value of nearly $1.1 billion, reflecting a 31.4% increase from 2022, compared to the industry growth of 4%.
CEO Jay Jackson expressed pride in the company's achievements and commitment to delivering exceptional value to clients.
$CRDL stock gave me a good opportunity to buy at a lower price yesterday. Now my average is $2.35. The chart is still very positive, and it’s just a matter of time; it could hit $3.50–3.75 very soon (technical breakout).
I have a strong feeling that we will get a positive outcome from the FDA for the company’s Phase II MAvERIC-Pilot study for CardiolRx (DUE IN JUNE). If we get this, then the sky is the limit and we may hit a double digit.
$OCX OncoCyte Corporation (NASDAQ: OCX) is currently one of the hottest stocks in the precision diagnostics space. One of the more innovative products in its portfolio is VitalGraft, a blood test for monitoring solid organ transplants. Here’s a closer look into the potential long term winner.
https://www.nasdaq.com/press-release/oncocytes-innovative-approach-potential-precision-diagnostics-2024-06-05
Going to be interesting to see if E-Trade actually bans the "kitty" from its platform 😂 I say no, but who ever knows....
If they do ban him, i guess i owe FURU Bao an apology. The aforementioned FURU has been claiming for years now that he made over $1 million shorting FNMA in a few hours. Afterwards, he claimed the MM's got together and forced his broker to ban him, as to not bring down the entire market 😂 Seriously folks, Hollywood couldn't make this stuff up no matter how hard they tried. lol
imho
BIG BREAKOUT ALERT - $CRDL made another bullish move and closed almost at HOD after hitting a new 3-year high. Higher highs and higher lows, along with increased volume—Beautiful technical setup. Even at this level, one can consider $CRDL, as it looks like we can see about $3.7–$3.75 soon.
The momentum trader must take a look at the chart and decide!!! I have been holding since $2.30 and have no plan to sell before $5.
$22.40 and chugging along
$VVPR - VivoPower (Nasdaq: VVPR) subsidiary Tembo makes major breakthrough with the launch of its entirely electric pickup utility vehicle. Investors would be even more excited at the innovative low capital worldwide supply chain. The stock seems undervalued and on my top watchlist considering its trading right at the multi-month support.
https://finance.yahoo.com/news/vivopower-tembo-launches-full-electric-121000510.html
$MMA - The MMA/combat sports gym and training industry is now worth $12.6 billion (as of 2023) Take a look at Alta Groups (NYSE:MMA) Hype acquisition and why they are a major force in this growing sector. https://finance.yahoo.com/news/alta-global-group-hype-acquisition-153000128.html
$CRDL – Higher Highs & Higher Lows Signal New High Soon
After flying 170% so far this year, $CRDL has witnessed impressive consolidation this month and is getting ready to break a new high. Once, the takes out $2.45-2.50, there could not be any major hurdle at least before $3-3.25. Fundamentally too, the stock is way undervalued.
The next big trigger for the stock is a pending FDA decision in June. It looks like the stock is setting up well for another leg of the rally. $CRDL must be on your watch list.
NNE $8.30 from $5.10 there is a god lol
LNBY(1.31)...potential RM with Xinsheng New Media......
I purchased some shares of the LNBY shell in late April at 40 cents. The sale of the control block (a little under 29.4M shares) was completed on April 23. I believe there are around 400-600K legacy shares (of which about 205K are owned by the previous owner and her husband). As with any reverse merger the quality of the RM target and final structure of the deal will be crucial. But the risk/reward looked pretty interesting to me. If the final legacy share count does turn out to be around this 400-600K level, then I think LNBY has a fairly decent chance of seeing prices at $3 or higher.
The reverse merger target appears to be Xinsheng New Media, and it seems to be fully-intent on reaching a listing on the Nasdaq by the end of 2026. Apparently it is already working with a company that has assisted other Chinese companies in getting Nasdaq listings. Xinsheng is heavily involved in live e-commerce education and talent, involved in things like movie/TV series production (with an emphasis on short-form kind of content that can gain popularity quickly and generate revenue on social media platforms), edge AI robots, etc.
I don't know how realistic their revenue projection is, so take the following information for what it is worth. If I am interpreting/understanding the company development path timeline and numbers correctly, Xinsheng New Media is projecting that by the end of 2026 the company will be generating around $2.75B US dollars in revenue.......
By 2026.12, the number of fans in all the company's live broadcast rooms will reach 300 million+, the revenue of the live broadcast room will be at least 200 billion+, the group's revenue will be at least 20 billion, the company's market value will exceed one trillion, and the Nasdaq listing plan will be fully realized
Followers
|
178
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
5942
|
Created
|
02/02/12
|
Type
|
Free
|
Moderator Involuntary-Recluse | |||
Assistants TURCH puffadder |
Identify and target the following opportunities:
Posts Today
|
1
|
Posts (Total)
|
5942
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |